Dalarna County Council, Sweden   Report issue

Government Phase 4
Founded: Sweden (1997)

Organization Overview

First Clinical Trial
2017
NCT04459377
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Center for Clinical Research Dalarna | Center for Clinical Research Dalarna, Sweden | Dalarna County Council, Sweden

Active Ingredients

Drugs in Phase 4 Trials (4)

esketamine (spravato) (1 trial)

methotrexate (1 trial)

prednisolone (hydeltra) (2 trials)

sodium chloride (1 trial)

Drugs in Other Trials (1)

oxygen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bell Palsy (Phase 4)

Borrelia Infections (Phase 4)

Facial Nerve Diseases (Phase 4)

Facial Paralysis (Phase 4)

Facies (Phase 4)

Nervous System Diseases (Phase 4)

Paralysis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5